Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection. | Liver Cancer;5(3): 221-32, 2016 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection.

Zhang, Bingnan; Finn, Richard S.

Affiliation

Zhang B; Division of Hematology Oncology Geffen School of Medicine at UCLA, Los Angeles, Calif., USA.
Finn RS; Division of Hematology Oncology Geffen School of Medicine at UCLA, Los Angeles, Calif., USA.

Liver Cancer ; 5(3): 221-32, 2016 Jul.

Article in En | MEDLINE | ID: mdl-27493897

Key words

Biomarkers; HCC; Liver cancer; Molecular therapy; Tivantinib

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Liver Cancer Year: 2016 Document type: Article Affiliation country: United States Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Liver Cancer Year: 2016 Document type: Article Affiliation country: United States Country of publication: Switzerland